Shanghai MicuRx Pharmaceutical Co Ltd Class A 688373
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 24.07
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Shanghai MicuRx Pharmaceutical Co Ltd is engaged in the discovery, development and commercialization of innovative medicines for unmet clinical needs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 205
- Website
- http://www.micurxchina.com
Comparables
Valuation
|
Metric
|
688373
|
300142
|
688321
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 59.29 | — |
Price/Book Value | 4.03 | 1.88 | 4.11 |
Price/Sales | 24.07 | 5.26 | 11.66 |
Price/Cash Flow | — | 16.40 | — |
Price/Earnings
688373
300142
688321
Financial Strength
|
Metric
|
688373
|
300142
|
688321
|
|---|---|---|---|
Quick Ratio | 7.39 | 2.51 | 1.96 |
Current Ratio | 8.27 | 2.94 | 2.84 |
Interest Coverage | −48.85 | 24.73 | −2.67 |
Quick Ratio
688373
300142
688321
Profitability
|
Metric
|
688373
|
300142
|
688321
|
|---|---|---|---|
Return on Assets (Normalized) | −44.18% | 1.93% | −3.63% |
Return on Equity (Normalized) | −60.16% | 3.16% | −6.83% |
Return on Invested Capital (Normalized) | −46.93% | 2.01% | −3.78% |
Return on Assets
688373
300142
688321
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Gtyqfksy | Lwcz | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Dggrbhqz | Gklrlq | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Dmvnscgy | Dlkj | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Kjxlwkx | Fxp | $19.0 Bil | |||
| Viatris Inc
VTRS
| Zjyqswhm | Xskl | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Bhthnglyl | Dvrq | $13.4 Bil | |||
| Catalent Inc
CTLT
| Wfqgdqj | Rjflc | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Fzkfvqdyv | Kvngpy | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Jmkzfbwx | Gjzh | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Cyspjfcsb | Yhsk | $2.5 Bil |
United States